Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

Nature

Volumn 436, Issue 7049, 2005, Pages 356-362

  Yang, Qin ^a   Graham, Timothy E ^a   Mody, Nimesh ^a   Preitner, Frederic ^a   Peroni, Odile D ^a   Zabolotny, Janice M ^a   Kotani, Ko ^a   Quadro, Loredana ^b,c   Kahn, Barbara B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Columbia University ^*  (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; DISEASE CONTROL; DISEASES; DNA; DNA SEQUENCES; DRUG DOSAGE; INSULIN; MUSCLE;

BINDING PROTEINS; DNA ARRAYS; INSULIN RESISTANCE; LIVER;

ENZYMES;

FENRETINIDE; INSULIN; PROTEIN RBP4; RECOMBINANT PROTEIN; RETINOL BINDING PROTEIN; ROSIGLITAZONE; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 4; MUSCLE PROTEIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RBP4 PROTEIN, MOUSE; SLC2A4 PROTEIN, MOUSE;

DIABETES;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE DELETION; GLUCOSE INTOLERANCE; HUMAN; INJECTION; INSULIN RESISTANCE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIPID DIET; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; URINARY EXCRETION; ANIMAL; BLOOD; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER CELL; METABOLISM; MOUSE MUTANT; MUSCLE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALIA;

ADIPOSE TISSUE; ANIMALS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; HEPATOCYTES; INSULIN; INSULIN RESISTANCE; LIVER; MICE; MICE, KNOCKOUT; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLES; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RETINOL-BINDING PROTEINS; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES;

EID: 22944434929     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03711     Document Type: Article

References (50)

1. Despres, J. P. et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334, 952-957 (1996).
2. Shepherd, P. R. & Kahn, B. B. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 341, 248-257 (1999).
3. DeFronzo, R. A. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev. 5, 171-269 (1997).
4. Shepherd, P. R. et al. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. J. Biol. Chem. 268, 22243-22246 (1993).
5. Abel, E. D. et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409, 729-733 (2001).
6. Tozzo, E., Gnudi, L. & Kahn, B. B. Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter. Endocrinology 138, 1604-1611 (1997).
7. Carvalho, E., Kotani, K., Peroni, O. & Kahn, B. B. Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am. J. Physiol. Endocrinol. Metab. doi:10.1152/ajpendo.0016.2005(2005).
8. Kershaw, E. E. & Flier, J. S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548-2556 (2004).
9. Quadro, L. et al. Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J. 18, 4633-4644 (1999).
10. Minokoshi, Y., Kahn, C. R. & Kahn, B. B. Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis. J. Biol. Chem. 278, 33609-33612 (2003).
11. Kitamura, T., Kahn, C. R. & Accili, D. Insulin receptor knockout mice. Annu. Rev. Physiol. 65, 313-332 (2003).
12. Blaner, W. S. Retinol-binding protein: the serum transport protein for vitamin A. Endocr. Rev. 10, 308-316 (1989).
13. Kotani, K., Peroni, O. D, Minokoshi, Y., Boss, O. & Kahn, B. B. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. J. Clin. Invest. 114, 1666-1675 (2004).
14. Masuzaki, H. et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 294, 2166-2170 (2001).
15. Minokoshi, Y. et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569-574 (2004).
16. Nikoulina, S. E. et al. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 49, 263-271 (2000).
17. Lee, C. H., Olson, P. & Evans, R. M. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144, 2201-2207 (2003).
18. Kotani, K., Kim, Y. B., Peroni, O., Mundt, A. & Kahn, B. B. Rosiglitazone treatment normalizes glucose tolerance in adipose-specific GLUT4 knockout mice but renders muscle-specific GLUT4 knockout more diabetic [abstract]. Diabetes 50, A274 (2001).
19. Quadro, L. et al. Muscle expression of human retinol-binding protein (RBP). Suppression of the visual defect of RBP knockout mice. J. Biol. Chem. 277, 30191-30197 (2002).
20. Naylor, H. M. & Newcomer, M. E. The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochemistry 38, 2647-2653 (1999).
21. Kato, M., Kato, K., Blaner, W. S., Chertow, B. S. & Goodman, D. S. Plasma and cellular retinoid-binding proteins and transthyretin (prealbumin) are all localized in the islets of Langerhans in the rat. Proc. Natl Acad. Sci. USA 82, 2488-2492 (1985).
22. Malpeli, G., Folli, C. & Berni, R. Retinoid binding to retinol-binding protein and the interference with the interaction with transthyretin. Biochim. Biophys. Acta 1294, 48-54 (1996).
23. Mothe, I. & Van Obberghen, E. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J. Biol. Chem. 271, 11222-11227 (1996).
24. Anai, M. et al. Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats. Diabetes 48, 158-169 (1999).
25. Pagliassotti, M. J., Kang, J., Thresher, J. S., Sung, C. K. & Bizeau, M. E. Elevated basal Pl 3-kinase activity and reduced insulin signalling in sucrose-induced hepatic insulin resistance. Am. J. Physiol. Endocrinol. Metab. 282, E170-E176 (2002).
26. Shin, D. J., Odom, D. P., Scribner, K. B., Ghoshal, S. & McGrane, M. M. Retinoid regulation of the phosphoenolpyruvate carboxykinase gene in liver. Mol. Cell. Endocrinol. 195, 39-54 (2002).
27. Kahn, C. R., Lauris, V., Koch, S., Crettaz, M. & Granner, D. K. Acute and chronic regulation of phosphoenolpyruvate carboxykinase mRNA by insulin and glucose. Mol. Endocrinol. 3, 840-845 (1989).
28. Wang, J. C., Stafford, J. M., Scott, D. K., Sutherland, C. & Granner, D. K. The molecular physiology of hepatic nuclear factor 3 in the regulation of gluconeogenesis. J. Biol. Chem. 275, 14717-14721 (2000).
29. Basualdo, C. G., Wein, E. E. & Basu, T. K. Vitamin A (retinol) status of First Nation adults with non-insulin-dependent diabetes mellitus. J. Am. Coll. Nutr. 16, 39-45 (1997).
30. Abahusain, M. Á., Wright, J., Dickerson, J. W. & de Vol, E. B. Retinol, alpha-tocopherol and carotenoids in diabetes. Eur. J. Clin. Nutr. 53, 630-635 (1999).
31. 1c in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes 51, 833-840 (2002).
32. Duggirala, R. et al. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am. J. Hum. Genet. 64, 1127-1140 (1999).
33. Tsutsumi, C. et al. Retinoids and retinoid-binding protein expression in rat adipocytes. J. Biol. Chem. 267, 1805-1810 (1992).
34. Zovich, D. C. et al. Differentiation-dependent expression of retinoid-binding proteins in BFC-1β adipocytes. J. Biol. Chem. 267, 13884-13889 (1992).
35. Pedersen, O., Kahn, C. R. & Kahn, B. B. Divergent regulation of the Glut 1 and Glut 4 glucose transporters in isolated adipocytes from Zucker rats. J. Clin. Invest. 89, 1964-1973 (1992).
36. Chambon, P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10, 940-954 (1996).
37. Koistinen, H. A. et al. Dyslipidemia and a reversible decrease in insulin sensitivity induced by therapy with 13-cis-retinoic acid. Diabetes Metab. Res. Rev. 17, 391-395 (2001).
38. Rodondi, N. et al. High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: a pharmacogenetic study. Ann. Intern. Med. 136, 582-589 (2002).
39. Kliewer, S. A., Xu, H. E., Lambert, M. H. & Willson, T. M. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog. Horm. Res. 56, 239-263 (2001).
40. Sivaprasadarao, A. & Findlay, J. B. The interaction of retinol-binding protein with its plasma-membrane receptor. Biochem. J. 255, 561-569 (1988).
41. Matarese, V. & Lodish, H. F. Specific uptake of retinol-binding protein by variant F9 cell lines. J. Biol. Chem. 268, 18859-18865 (1993).
42. Christensen, E. I. et al. Evidence for an essential role of megalin in transepithelial transport of retinol. J. Am. Soc. Nephrol. 10, 685-695 (1999).
43. Berni, R., Clerici, M., Malpeli, G., Cleris, L. & Formelli, F. Retinoids: in vitro interaction with retinol-binding protein and influence on plasma retinol. FASEB J. 7, 1179-1184 (1993).
44. Monaco, H. L. The transthyretin-retinol-binding protein complex. Biochim. Biophys. Acta 1482, 65-72 (2000).
45. Sheikh, M. S. et al. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma. Carcinogenesis 16, 2477-2486 (1995).
46. Um, S. J. et al. Antiproliferative mechanism of retinoid derivatives in ovarian cancer cells. Cancer Lett. 174, 127-134 (2001).
47. Shen, Q., Cline, G. W., Shulman, G. I., Leibowitz, M. D. & Davies, P. J. Effects of rexinoids on glucose transport and insulin-mediated signalling in skeletal muscles of diabetic (db/db) mice. J. Biol. Chem. 279, 19721-19731 (2004).
48. Subcommittee on Laboratory Animal Nutrition, Committee on Animal Nutrition, Board on Agriculture, National Research Council. Nutrient Requirements of Laboratory Animals 4th revised edn, 92 (National Academies Press, Washington DC, 1995).
49. Wang, T. T., Lewis, K. C. & Phang, J. M. Production of human plasma retinol-binding protein in Escherichia coli. Gene 133, 291-294 (1993).
50. Xie, Y., Lashuel, H. A., Miroy, G. J., Dikler, S. & Kelly, J. W. Recombinant human retinol-binding protein refolding, native disulfide formation, and characterization. Protein Expr. Purif. 14, 31-37 (1998).